The clinical staging results showed (Figure 6) that RBP1 expression was higher in higher stages of BLCA, COAD and TGCT and lowered in higher stages of mesothelioma (MESO), BRCA and ESCA. This evidence concerns the gene RBP1 and bladder transitional cell carcinoma.